Alentis Therapeutics Starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis
Published on: Monday 03 January 2022
BASEL, Switzerland, January 04, 2022--(BUSINESS WIRE)--Alentis Therapeutics, AG today announced it has dosed the first cohort of healthy participants in a first-in-human Phase 1 clinical trial of ...
